Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro

被引:33
|
作者
Govindan, Suresh [1 ]
Sarkey, Jason [1 ]
Ji, Xiang [1 ]
Sundaresan, Nagalingam R. [2 ]
Gupta, Mahesh P. [2 ]
de Tombe, Pieter P. [1 ]
Sadayappan, Sakthivel [1 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA
[2] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
Proteolysis; Pathogenesis; Muscle contractility; Actin; Acetylation; Ca2+; Transients; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; REGULATORY DOMAIN; HEART-MUSCLE; F-ACTIN; PHOSPHORYLATION; TROPONIN; CONTRACTILITY; ACTIVATION; BIOMARKER;
D O I
10.1007/s10974-012-9292-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia-reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca2+ transients, contractility, and protein-protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca2+ handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca2+ handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0-C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca2+ handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [41] Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction
    Govindan, Suresh
    McElligott, Andrew
    Muthusamy, Saminathan
    Nair, Nandini
    Barefield, David
    Martin, Jody L.
    Gongora, Enrique
    Greis, Kenneth D.
    Luther, Pradeep K.
    Winegrad, Saul
    Henderson, Kyle K.
    Sadayappan, Sakthivel
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 52 (01) : 154 - 164
  • [42] Usefulness of Released Cardiac Myosin Binding Protein-C as a Predictor of Cardiovascular Events
    Tong, Carl W.
    Dusio, Giuseppina F.
    Govindan, Suresh
    Johnson, Dustin W.
    Kidwell, David T.
    De La Rosa, Lisa M.
    Rosas, Paola C.
    Liu, Yang
    Ebert, Elizabeth
    Newell-Rogers, M. Karen
    Michel, Jeffrey B.
    Trzeciakowski, Jerome P.
    Sadayappan, Sakthivel
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (09) : 1501 - 1507
  • [43] The C0C1 Fragment of Human Cardiac Myosin Binding Protein C Has Common Binding Determinants for Both Actin and Myosin
    Lu, Yanling
    Kwan, Ann H.
    Trewhella, Jill
    Jeffries, Cy M.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 413 (05) : 908 - 913
  • [44] Kinetics of cardiac myosin isoforms in mouse myocardium are affected differently by presence of myosin binding protein-C
    Tanner, Bertrand C. W.
    Wang, Yuan
    Robbins, Jeffrey
    Palmer, Bradley M.
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2014, 35 (5-6) : 267 - 278
  • [45] Molecular modulation of actomyosin function by cardiac myosin-binding protein C
    Previs, Michael J.
    Michalek, Arthur J.
    Warshaw, David M.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2014, 466 (03): : 439 - 444
  • [46] Cryo-Electron Microscopy Reveals Cardiac Myosin Binding Protein-C M-Domain Interactions with the Thin Filament
    Risi, Cristina M.
    Villanueva, Edwin
    Belknap, Betty
    Sadler, Rachel L.
    Harris, Samantha P.
    White, Howard D.
    Galkin, Vitold E.
    JOURNAL OF MOLECULAR BIOLOGY, 2022, 434 (24)
  • [47] Cardiac myosin binding protein-C: Redefining its structure and function
    Sadayappan S.
    de Tombe P.P.
    Biophysical Reviews, 2012, 4 (2) : 93 - 106
  • [48] Myosin Binding Protein-C: A Regulator of Actomyosin Interaction in Striated Muscle
    Ackermann, Maegen A.
    Kontrogianni-Konstantopoulos, Aikaterini
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [49] Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes
    McNamara, James W.
    Li, Amy
    Smith, Nicola J.
    Lal, Sean
    Graham, Robert M.
    Kooiker, Kristina Bezold
    van Dijk, Sabine J.
    dos Remedios, Cristobal G.
    Harris, Samantha P.
    Cooke, Roger
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 94 : 65 - 71
  • [50] Structure before function: myosin binding protein-C slow is a structural protein with regulatory properties
    Geist, Janelle
    Ward, Christopher W.
    Kontrogianni-Konstantopoulos, Aikaterini
    FASEB JOURNAL, 2018, 32 (12) : 6385 - 6394